Oh Sang Cheul相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Phase Ib/II Study of Zanidatamab in Combination with Tislelizumab and Chemotherapy in First-Line HER2-Positive Gastric/Gastroesophageal Junction Adenocarcinoma

Zanidatamab联合Tislelizumab和化疗一线治疗HER2阳性胃/胃食管交界处腺癌的Ib/II期研究

期刊:Clinical Cancer Research

影响因子:10.2

doi:10.1158/1078-0432.CCR-24-4295

Lee, Keun-Wook; Bai, Li-Yuan; Jung, Minkyu; Ying, Jieer; Im, Young-Hyuck; Oh, Do-Youn; Cho, Jae Yong; Oh, Sang Cheul; Chao, Yee; Kim, Jin Won; Chen, Ye; Li, Vincent; Chen, Shengnan; Kang, Yoon-Koo

发表日期：2026

文献求助收藏

Predictors of overall survival in advanced biliary tract cancer in the phase 3 TOPAZ-1 study

TOPAZ-1 3期研究中晚期胆道癌患者总生存期的预测因素

期刊:Hepatology Communications

影响因子:4.6

doi:10.1097/HC9.0000000000000868

He, Aiwu R; Bouattour, Mohamed; Gupta, Vineet G; Evesque, Ludovic; Zhen, David B; Park, Joon Oh; Sookprasert, Aumkhae; Salvatierra, Alejandro; Vaccaro, Gina; Oh, Sang Cheul; Ostoich, Sandra Anabel; Satoh, Taroh; Kuzko, Aleksandra; Żotkiewicz, Magdalena; Rokutanda, Nana; Oh, Do-Youn

发表日期：2026

文献求助收藏

Nivolumab plus chemotherapy in Asian people with advanced or recurrent stomach or gastroesophageal junction cancer (ATTRACTION-4 study): a plain language summary

纳武利尤单抗联合化疗治疗亚洲晚期或复发性胃癌或胃食管交界处癌患者（ATTRACTION-4 研究）：简明语言摘要

期刊:Future Oncology

影响因子:2.6

doi:10.1080/14796694.2026.2622806

Chen, Li-Tzong; Kang, Yoon-Koo; Ryu, Min-Hee; Oh, Do-Youn; Oh, Sang Cheul; Rha, Sun Young; Lee, Keun-Wook; Omori, Takeshi; Shitara, Kohei; Sakuramoto, Shinichi; Chung, Ik-Joo; Yamaguchi, Kensei; Kato, Ken; Sym, Sun Jin; Kadowaki, Shigenori; Tsuji, Kunihiro; Chen, Jen-Shi; Bai, Li-Yuan; Oh, Sung-Yong; Choda, Yasuhiro; Yasui, Hisateru; Takeuchi, Kentaro; Hirashima, Yoshinori; Hagihara, Shunsuke; Boku, Narikazu

发表日期：2026

文献求助收藏

Synergistic Anticancer Effects of Fibroblast Growth Factor Receptor Inhibitor and Cannabidiol in Colorectal Cancer

成纤维细胞生长因子受体抑制剂与大麻二酚在结直肠癌中的协同抗癌作用

期刊:Nutrients

doi:10.3390/nu17162609

Ju, Yeonuk; Kim, Bu Gyeom; Gim, Jeong-An; Bong, Jun Woo; Cheong, Chin Ock; Oh, Sang Cheul; Kang, Sang Hee; Min, Byung Wook; Lee, Sun Il

成纤维细胞

细胞生物学

发表日期：2025

文献求助收藏

Trans cinnamaldehyde enhances TRAIL induced apoptosis through ER stress mediated upregulation of DR5 in colorectal cancer cells.

反式肉桂醛通过内质网应激介导的DR5上调增强TRAIL诱导的结直肠癌细胞凋亡。

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-20306-0

Kim Dae Yeong, Kim Bu Gyeom, Yun Hye Mi, Kim Ok Hyeon, Kang Sanghee, Bong Jun-Woo, Lee Sun Il, Kim Bo Ram, Oh Sang Cheul

细胞生物学

内质网应激

发表日期：2025

文献求助收藏

Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial

Bemarituzumab 作为局部晚期或转移性胃/胃食管交界处腺癌的一线治疗：随机 II 期 FIGHT 试验的最终分析

期刊:Gastric Cancer

影响因子:5.1

doi:10.1007/s10120-024-01466-w

Wainberg, Zev A; Kang, Yoon-Koo; Lee, Keun-Wook; Qin, Shukui; Yamaguchi, Kensei; Kim, In-Ho; Saeed, Anwaar; Oh, Sang Cheul; Li, Jin; Turk, Haci Mehmet; Teixeira, Alexandra; Hitre, Erika; Udrea, Adrian A; Cardellino, Giovanni Gerardo; Sanchez, Raquel Guardeño; Zahlten-Kümeli, Anita; Taylor, Kate; Enzinger, Peter C

发表日期：2024

文献求助收藏

Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis

Bemarituzumab联合mFOLFOX6作为一线治疗方案用于FGFR2b过表达的东亚局部晚期或转移性胃/胃食管交界处癌患者：FIGHT研究最终分析的亚组分析

期刊:Gastric Cancer

影响因子:5.1

doi:10.1007/s10120-024-01516-3

Kang, Yoon-Koo; Qin, Shukui; Lee, Keun-Wook; Oh, Sang Cheul; Kim, In-Ho; Kim, Jong Gwang; Li, Yong; Yan, Zhuchen; Li, Jin; Bai, Li-Yuan; Chan, Catherine; Yusuf, Akeem; Zahlten-Kümeli, Anita; Taylor, Kate; Yamaguchi, Kensei

发表日期：2024

文献求助收藏

Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 trial

纳武利尤单抗联合化疗治疗HER2阴性、既往未接受治疗、不可切除、晚期或复发性胃/胃食管交界处癌患者：ATTRACTION-4随机、双盲、安慰剂对照3期试验的3年随访结果

期刊:Gastric Cancer

影响因子:5.1

doi:10.1007/s10120-024-01535-0

Boku, Narikazu; Omori, Takeshi; Shitara, Kohei; Sakuramoto, Shinichi; Yamaguchi, Kensei; Kato, Ken; Kadowaki, Shigenori; Tsuji, Kunihiro; Ryu, Min-Hee; Oh, Do-Youn; Oh, Sang Cheul; Rha, Sun Young; Lee, Keun-Wook; Chung, Ik-Joo; Sym, Sun Jin; Chen, Li-Tzong; Chen, Jen-Shi; Bai, Li-Yuan; Nakada, Takashi; Hagihara, Shunsuke; Makino, Reina; Nishiyama, Eiji; Kang, Yoon-Koo

发表日期：2024

文献求助收藏

Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial

佐贝妥昔单抗联合卡泊芬净治疗CLDN18.2阳性胃或胃食管交界处腺癌：一项随机、3期GLOW试验

期刊:Nature Medicine

影响因子:50

doi:10.1038/s41591-023-02465-7

Shah, Manish A; Shitara, Kohei; Ajani, Jaffer A; Bang, Yung-Jue; Enzinger, Peter; Ilson, David; Lordick, Florian; Van Cutsem, Eric; Gallego Plazas, Javier; Huang, Jing; Shen, Lin; Oh, Sang Cheul; Sunpaweravong, Patrapim; Soo Hoo, Hwoei Fen; Turk, Haci Mehmet; Oh, Mok; Park, Jung Wook; Moran, Diarmuid; Bhattacharya, Pranob; Arozullah, Ahsan; Xu, Rui-Hua

发表日期：2023

文献求助收藏

Clinically conserved genomic subtypes of gastric adenocarcinoma.

胃腺癌的临床保守基因组亚型

期刊:Molecular Cancer

影响因子:33.9

doi:10.1186/s12943-023-01796-w

Jeong Yun Seong, Eun Young-Gyu, Lee Sung Hwan, Kang Sang-Hee, Yim Sun Young, Kim Eui Hyun, Noh Joo Kyung, Sohn Bo Hwa, Woo Seon Rang, Kong Moonkyoo, Nam Deok Hwa, Jang Hee-Jin, Lee Hyun-Sung, Song Shumei, Oh Sang Cheul, Lee Jeeyun, Ajani Jaffer A, Lee Ju-Seog

发表日期：2023

文献求助收藏